CAS RN: 1496637-09-2

(S)-4-oxide-2,6-bisbis([1,1′:3′,1”-terphenyl]-5′-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin

Product Availability

Choose a grade to view its available package options.

5 package records4 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251017 50mg / 100mg / 250mg / 1g Out of stock 5-7 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20251022 100mg In stock Shanghai Inquiry
Batchno.20251110 1g In stock Tianjin Inquiry
Batchno.20250611 250mg In stock Shanghai, Tianjin Inquiry
Batchno.20250923 50mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1496637-09-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1496637-09-2 / 10,16-bis(3,5-diphenylphenyl)-13-hydroxy-12,14-dioxa-13lambda5-phosphapentacyclo[13.8.0.02,11.03,8.018,23]tricosa-1(23),2,8,10,15,17-hexaene 13-oxide

Standard CAS: 1496637-09-2 Multi CAS: No

Basic Information

CAS
1496637-09-2
Multi CAS
No
Molecular Formula
C56H45O4P
Molecular Weight
812.900000
Exact Mass
812.305547
SMILES
C1CCC2=C3C4=C5CCCCC5=CC(=C4OP(=O)(OC3=C(C=C2C1)C6=CC(=CC(=C6)C7=CC=CC=C7)C8=CC=CC=C8)O)C9=CC(=CC(=C9)C1=CC=CC=C1)C1=CC=CC=C1
InChI
InChI=1S/C56H45O4P/c57-61(58)59-55-51(47-31-43(37-17-5-1-6-18-37)29-44(32-47)38-19-7-2-8-20-38)35-41-25-13-15-27-49(41)53(55)54-50-28-16-14-26-42(50)36-52(56(54)60-61)48-33-45(39-21-9-3-10-22-39)30-46(34-48)40-23-11-4-12-24-40/h1-12,17-24,29-36H,13-16,25-28H2,(H,57,58)
InChIKey
OCAULRBATWHQOB-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
61
Aromatic heavy atom count
48
Fraction Csp3
0.14
Rotatable bonds
6
H-bond acceptors
3
H-bond donors
1
Molar refractivity
248.86
TPSA
55.76

LogP / Solubility

WLOGP
14.98
MLOGP
13.26
XLogP3
14.8
Consensus LogP
14.35
Log S (ESOL)
-14.51
Class (ESOL)
Insoluble
Log S (Ali)
-17.05
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-18.1
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
2.96

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
8

Get In Touch

Contact Us